Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of IV Iron on Cardiopulmonary Physiology at High Altitude
NCT03707249Completed
- Sponsor
- Royal Centre for Defence Medicine
- Start
- Jan 2016
- Primary completion
- May 2016
- Modality
- Small Molecules
01
Overview
Randomised, single-blind trial of ferric carboxymaltose in hypoxia (2 arms), sponsored by Royal Centre for Defence Medicine. Primary endpoints: Right Ventricular Systolic Pressure at 2 weeks, Time from pulmonary valve opening to peak pulmonary flow velocity at 2 weeks and 6 more. Started Jan 2016; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
hypoxia
Beyond the preview
Go deeper on NCT03707249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03707249.